Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pharmacyte Biotech Inc (PMCB)

Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,068
  • Shares Outstanding, K 6,796
  • Annual Sales, $ 0 K
  • Annual Income, $ 30,660 K
  • EBIT $ -4 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.17

Options Overview Details

View History
  • Implied Volatility 154.96% (-35.28%)
  • Historical Volatility 171.13%
  • IV Percentile 12%
  • IV Rank 8.39%
  • IV High 1,144.99% on 01/16/25
  • IV Low 64.32% on 09/15/25
  • Expected Move (DTE 7) 1.9040 (186.67%)
  • Put/Call Vol Ratio 0.03
  • Today's Volume 387
  • Volume Avg (30-Day) 1,487
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 16,793
  • Open Int (30-Day) 4,950
  • Expected Range 0.0000 to 2.9240

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6300 +61.90%
on 11/24/25
1.5100 -32.45%
on 12/05/25
+0.1420 (+16.17%)
since 11/11/25
3-Month
0.6300 +61.90%
on 11/24/25
1.5100 -32.45%
on 12/05/25
-0.0100 (-0.97%)
since 09/11/25
52-Week
0.6300 +61.90%
on 11/24/25
1.9000 -46.32%
on 02/21/25
-0.6400 (-38.55%)
since 12/11/24

Most Recent Stories

More News
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced the successful monetization of its stake in Femasys Inc. (NASDAQ: FEMY), further validating the Company’s...

PMCB : 1.0200 (-1.92%)
FEMY : 0.8551 (-0.87%)
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner’s 2025 Hype Cycle for Data Center Infrastructure...

PMCB : 1.0200 (-1.92%)
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced the closing of its previously announced $7 million financing. As of April 30, 2025, PharmaCyte had...

PMCB : 1.0200 (-1.92%)
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”) announced today that it has entered into a securities purchase agreement for a $7.0 million financing with existing investors...

PMCB : 1.0200 (-1.92%)
PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan

PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), a biotechnology company focused on evaluating its signature live-cell encapsulation technology, Cell-in-a-Box ® for potential...

PMCB : 1.0200 (-1.92%)
PharmaCyte Biotech Reaches Cooperation Agreement with Iroquois Capital

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 1.0200 (-1.92%)
PharmaCyte Biotech Rebukes Iroquois’ Commencement of Consent Solicitation

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 1.0200 (-1.92%)
PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 1.0200 (-1.92%)
PharmaCyte Biotech Reports Positive Interim Results in Malignant Ascites Mouse Model Study

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 1.0200 (-1.92%)
PharmaCyte Biotech Announces Preliminary Unaudited Financial Results for Fiscal Year 2022

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 1.0200 (-1.92%)

Business Summary

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is...

See More

Key Turning Points

3rd Resistance Point 1.2667
2nd Resistance Point 1.1933
1st Resistance Point 1.1067
Last Price 1.0200
1st Support Level 0.9467
2nd Support Level 0.8733
3rd Support Level 0.7867

See More

52-Week High 1.9000
Fibonacci 61.8% 1.4149
Fibonacci 50% 1.2650
Fibonacci 38.2% 1.1151
Last Price 1.0200
52-Week Low 0.6300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar